INS and metabolic dysfunction-associated steatotic liver disease: Given the established links between insulin resistance and the development of NAFLD (3), it is possible that IGFBP-2 contributes indirectly to a low LF phenotype by enhancing insulin sensitivity despite the presence of visceral obesity.